Nursing RoleNCT07049510
Combating Violence Against Women
A study testing Experimental: Experimental: Combating violence against women in people with Nursing Role, run by Hitit University at 1 site in Turkey (Türkiye).
Trial summary
The aim of the study was to investigate the effect of the program to combat violence against women on domestic violence awareness and gender role attitudes. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Nursing Role
- What is being tested?
- Experimental: Experimental: Combating violence against women
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 62 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 28 May 2025to 15 Sep 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Women between the ages of 18-45,
- Who speaks Turkish,
- Who has previously applied to law enforcement due to violence,
- Women who volunteer to participate in the research.
Who cannot join
- Women diagnosed with a psychiatric illness.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Effect of the Programme on Combating Violence Against Women on Domestic Violence Awareness and Gender Attitudes: A Randomized Controlled Trial
The aim of the study was to investigate the effect of the program to combat violence against women on domestic violence awareness and gender role attitudes.
Read the detailed description
Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale will be used in collecting research data.
After the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training.
No intervention will be made to the control group.
- Conditions
- Nursing Role
- Being tested
- Experimental: Experimental: Combating violence against women
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Experimental: Experimental: Combating violence against womenBehavioural
After the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training.
8 weeks after the completion of the training, all women will be reunited and the Domestic Violence Awareness Scale and Gender Role Attitude Scale will be applied as a post-test.
| Study group | Role | What they receive |
|---|---|---|
| Active Comparator: Control group | Active comparator | All women will be given the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale as a pre-test. No intervention will be made to the control group. After 8 weeks, all women will be reunited and given the Domestic Violence Awareness Scale and Gender Role Attitude Scale as a post-test. Receives: Behavioral: Experimental: Experimental: Combating violence against women |
| Combating violence against women | Experimental | After the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training.
8 weeks after the completion of the training, all women will be reunited and the Domestic Violence Awareness Scale and Gender Role Attitude Scale will be applied as a post-test. Receives: Behavioral: Experimental: Experimental: Combating violence against women |
What is being measured
The primary outcome is the main question the study is designed to answer.
Domestic Violence Awareness Scale
The scale developed by Özyürek and Kurnaz (2019) consists of 20 items measuring awareness of domestic violence on a three-point Likert scale. The highest score that can be obtained from each item is three, and the lowest score is one. Items 1-5 in the scale constitute the sub-dimensions of "Definition of Domestic Violence", items 6-10 constitute the sub-dimensions of "Consequences of Domestic Violence", items 11-15 constitute the sub-dimensions of "Acceptance of Domestic Violence", and items 16-20 constitute the sub-dimensions of "Normalization of Domestic Violence". High total scores obtained from the entire scale can be interpreted as the individual having views compatible with the expected behaviors and attitudes in scientific and legal fields in interpreting domestic violence and having a high level of awareness of domestic violence. The Cronbach alpha coefficient of the scale was reported to be 0.92 and ranged between 0.71 and 0.92 for its sub-dimensions. In this study, Cronbach
Measured: 2 months
Secondary outcomes (1)
Gender Roles Attitude Scale
Gender Roles Scale was originally developed by García-Cueto and colleagues (2015). Adaptation of the scale to Turkish and reliability validity study were conducted by Bakioğlu and Türküm (2019). In the original study, Cronbach alpha internal consistency coefficient was calculated as 0.99 within the scope of reliability of the scale, in the adaptation study, Cronbach alpha internal consistency coefficient was calculated as 0.88 and test-retest reliability was calculated as 0.77. The scale consists of 15 questions and a single dimension. The items are answered in Likert type as 1= I completely disagree, 2= I disagree, 3= I am undecided, 4= I agree, 5= I completely agree and so on. The 13 items of the scale, except for items 1 and 2, are reverse coded. A total score is obtained from the scale, and a higher score indicates a higher negative attitude towards gender roles. In other words, a person who scores high on the scale adopts gender roles less and shows less commitment than a person
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jul 2025
- Study start28 May 2025
- Primary completion28 Jul 2025 (estimated)
- Study completion15 Sep 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Nursing RoleStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 62 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hitit University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Fatma Yildirim, Hitit University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07049510
- Sponsor's protocol ID
- Combating Violence Against Wom
- Status last verified
- Jun 2025
- First submitted
- 13 Jun 2025
- Last updated
- 3 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data will be shared with researchers who apply for appropriate use for research purposes only, with ethics committee approval.
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of the Programme on Combating Violence Against Women on Domestic Violence Awareness and Gender Attitudes: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07049510
- Acronym / sponsor ID
- Combating Violence Against Wom
- Conditions
- Nursing Role
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 62 participants (estimated)
- Lead sponsor
- Hitit UniversityUniversity, hospital or other
- Study start
- 28 May 2025 (actual)
- Primary completion
- 28 Jul 2025 (estimated)
- Study completion
- 15 Sep 2025 (estimated)
- First posted
- 3 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study was to investigate the effect of the program to combat violence against women on domestic violence awareness and gender role attitudes.
Detailed description
Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale will be used in collecting research data.
After the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training.
No intervention will be made to the control group.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Active Comparator: Control group | Active comparator | Behavioral: Experimental: Experimental: Combating violence against womenAll women will be given the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale as a pre-test. No intervention will be made to the control group. After 8 weeks, all women will be reunited and given the Domestic Violence Awareness Scale and Gender Role Attitude Scale as a post-test. |
| Combating violence against women | Experimental | Behavioral: Experimental: Experimental: Combating violence against womenAfter the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training. 8 weeks after the completion of the training, all women will be reunited and the Domestic Violence Awareness Scale and Gender Role Attitude Scale will be applied as a post-test. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Women between the ages of 18-45,
- Who speaks Turkish,
- Who has previously applied to law enforcement due to violence,
- Women who volunteer to participate in the research.
Key exclusion criteria (1 listed)
- Women diagnosed with a psychiatric illness.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Experimental: Experimental: Combating violence against womenAfter the Personal Information Form, Domestic Violence Awareness Scale and Gender Role Attitude Scale are applied to all women as a pre-test, the women in the experimental group will be included in the Combating Violence Against Women program. The program will be given in 4 sessions in 1 day. Demonstration, powerpoint, feedback and brainstorming methods will be used in the training. 8 weeks after the completion of the training, all women will be reunited and the Domestic Violence Awareness Scale and Gender Role Attitude Scale will be applied as a post-test. | Behavioural | Active Comparator: Control group, Combating violence against women |
Primary outcome
Domestic Violence Awareness Scale
Time frame: 2 months
The scale developed by Özyürek and Kurnaz (2019) consists of 20 items measuring awareness of domestic violence on a three-point Likert scale. The highest score that can be obtained from each item is three, and the lowest score is one. Items 1-5 in the scale constitute the sub-dimensions of "Definition of Domestic Violence", items 6-10 constitute the sub-dimensions of "Consequences of Domestic Violence", items 11-15 constitute the sub-dimensions of "Acceptance of Domestic Violence", and items 16-20 constitute the sub-dimensions of "Normalization of Domestic Violence". High total scores obtained from the entire scale can be interpreted as the individual having views compatible with the expected behaviors and attitudes in scientific and legal fields in interpreting domestic violence and having a high level of awareness of domestic violence. The Cronbach alpha coefficient of the scale was reported to be 0.92 and ranged between 0.71 and 0.92 for its sub-dimensions. In this study, Cronbach
1 secondary outcome
Gender Roles Attitude Scale
Time frame: 2 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2025.
- Individual participant dataSharing planned: Yes. De-identified individual participant data will be shared with researchers who apply for appropriate use for research purposes only, with ethics committee approval.
Related trials for Nursing Role
Not yet recruiting
Interpersonal Relational Role Analysis Group Therapy for Nursing Students at Risk of Internet Addiction
Internet Addiction
Recruiting
AI Simulation to Reduce Stigma and Enhance Psychiatric Readiness in Nursing Students
Mental Illness Stigma, Psychiatric Nursing
Not yet recruiting
The Effect of Creative Drama on the Therapeutic Communication Skills and Empathy Levels of Pediatric Nursing Students: A Randomized Controlled Study
Nurse's Role, Empathy
Active, not recruiting
Advancing Nursing Practices in Hospital Oncology Care
Gastrointestinal Cancer, Gastrointestinal Disease
Not yet recruiting
Effects of AI Dialogue-Based Scenario Simulation on Students' Flow and Learning Performance
Nursing Education
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Experimental: Experimental: Combating violence against women in people with Nursing Role, run by Hitit University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 3 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Domestic Violence Awareness Scale (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2025.